Ontario proposes removing barrier to listing “well-established drugs” on its public formulary
Federal Court: Transferring drug submission does not require re-serving Notice of Allegation
Guidance on inventor discovery and “invention story” evidence in Canadian patent actions: Federal Court rules in favour of patentee
Federal Court finds that Health Canada breached procedural fairness by relying on an undisclosed internal guidance document
Canada implements patent term adjustment as Bill C-47 becomes law
Health Canada releases updated Certificate of Supplementary Protection guidance
Bill C-47 introduces patent term adjustment: Proposed term to run concurrently with term of Certificate of Supplementary Protection
U.S. Trade Representative cites Canada’s “IP problems” including pharmaceutical patent protection
Canada announces its first-ever national strategy for drugs for rare diseases
Subscribe: Subscribe via RSS
Blogs
Firm/Org